1. Home
  2. SLDB vs NAMM Comparison

SLDB vs NAMM Comparison

Compare SLDB & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • NAMM
  • Stock Information
  • Founded
  • SLDB 2013
  • NAMM 2024
  • Country
  • SLDB United States
  • NAMM Cayman Islands
  • Employees
  • SLDB N/A
  • NAMM N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • NAMM
  • Sector
  • SLDB Health Care
  • NAMM
  • Exchange
  • SLDB Nasdaq
  • NAMM Nasdaq
  • Market Cap
  • SLDB 433.0M
  • NAMM 410.8M
  • IPO Year
  • SLDB 2018
  • NAMM N/A
  • Fundamental
  • Price
  • SLDB $5.13
  • NAMM $3.08
  • Analyst Decision
  • SLDB Strong Buy
  • NAMM
  • Analyst Count
  • SLDB 10
  • NAMM 0
  • Target Price
  • SLDB $15.00
  • NAMM N/A
  • AVG Volume (30 Days)
  • SLDB 872.0K
  • NAMM 391.6K
  • Earning Date
  • SLDB 11-05-2025
  • NAMM 01-01-0001
  • Dividend Yield
  • SLDB N/A
  • NAMM N/A
  • EPS Growth
  • SLDB N/A
  • NAMM N/A
  • EPS
  • SLDB N/A
  • NAMM N/A
  • Revenue
  • SLDB N/A
  • NAMM N/A
  • Revenue This Year
  • SLDB N/A
  • NAMM N/A
  • Revenue Next Year
  • SLDB N/A
  • NAMM N/A
  • P/E Ratio
  • SLDB N/A
  • NAMM N/A
  • Revenue Growth
  • SLDB N/A
  • NAMM N/A
  • 52 Week Low
  • SLDB $2.41
  • NAMM $2.56
  • 52 Week High
  • SLDB $8.45
  • NAMM $55.00
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 36.32
  • NAMM N/A
  • Support Level
  • SLDB $5.34
  • NAMM N/A
  • Resistance Level
  • SLDB $5.77
  • NAMM N/A
  • Average True Range (ATR)
  • SLDB 0.32
  • NAMM 0.00
  • MACD
  • SLDB -0.07
  • NAMM 0.00
  • Stochastic Oscillator
  • SLDB 8.74
  • NAMM 0.00

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About NAMM Namib Minerals Ordinary Shares

Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.

Share on Social Networks: